The abstract is read at the publisher; the summary is JClub's.
In 2419 lung transplant recipients, primary graft dysfunction (PGD) is linked to a lower maximum potential FEV1 by -311 ml and a -12.5% lower chance of achieving GLI-predicted FEV1.
- Why it matters: PGD after lung transplant is known to relate to higher mortality, but whether it also leaves long-term effects on allograft function and chronic lung allograft dysfunction (CLAD) is unclear.
- What they did: Using an 8-center prospective cohort (2007–2018), investigators defined PGD by ISHLT criteria and modeled associations with maximum potential FEV1 using linear mixed effects and logistic regression for GLI-predicted attainment.
- The result: Over a median 5.9 (3.0–8.0) years, the 5-year cumulative incidence of CLAD did not differ by PGD (difference -2.2%, 95% CI -6.4% to 1.9%), nor for obstructive (-1.2%) or restrictive (-0.8%) CLAD.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.